Mascarenhas, L., Albert, C., Federman, N., DuBois, S., Bielack, S., Orbach, D., & Gallego, S. (2025). Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal Tumors.
Citação norma ChicagoMascarenhas, Leo, Catherine Albert, Noah Federman, Steven DuBois, Stefan Bielack, Daniel Orbach, y Soledad Gallego. Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal Tumors. 2025.
Citação norma MLAMascarenhas, Leo, et al. Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal Tumors. 2025.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.